The market for orthobiologics is expected to grow at a CAGR of around 5.6% from 2020 to 2027 and expected to reach the market value of around US$ 7,725.6 Mn by 2027.
Orthobiologics are biological substances that help in quick heal of musculoskeletal injuries like fractures, injured muscles, tendons, and ligaments. These are made from the natural substances that occur in the body. The bone grafts, autologous blood, autologous conditioned serum, platelet-rich plasma, growth factors, and stem cells are considered as orthobiologics. Orthobiologics are used for the treatment associated with the knee, hip, ankle, spine, wrist, and other body parts.
Market Dynamics
The increasing incidence of sports injuries & road accidents, as well as increasing incidence of spinal diseases/disorders, are boosting the market value. The rising geriatric & obese population and growing patient preference for minimally invasive procedures in emerging markets is accelerating the market value. The emerging markets along with the rapid urbanization are projected to create potential opportunities over the forecast period from 2020 to 2027.
On the other side, high cost associated with orthobiologics-based treatments, post-surgery complications, and stringent regulatory approval is likely to hinder the growth to an extent over the estimated timeframe from 2020 to 2027.
Viscosupplementation Products is dominating the global Orthobiologics Market
By product, viscosupplementation products are the leading segment in the global market. The better reimbursement scenarios for the products in some economies like France are supporting the segmental market value. The approval for the use by the U.S. Food and Drug Administration (FDA) is additionally contributing to the segmental market value. Furthermore, the growing prevalence of lifestyle-induced disorders such as obesity is bolstering the segmental market value. The viscosupplementation products segment is also projected to exhibit the fastest growth with major CAGR (%) over the estimated period from 2020 to 2027.
North America registered maximum revenue share in the Orthobiologics Market
In 2019, North America was leading the global orthobiologics market owing to its advanced healthcare infrastructure. The rapidly growing geriatric population in the region is supporting the regional market value. The major economies of the region including the US and Canada are contributing to the regional market value. The increasing incidence of spinal disorders, growing physician, and patient awareness about newly introduced treatment procedures and technologies are propelling the regional market value. The consistent efforts made by industry players in promoting awareness associated with the orthobiological products are further bolstering the regional market value. The presence of major players in the region such as Globus Medical, Inc, Johnson and Johnson (J&J), and Medline Industries, Inc. among others is further supporting the regional market value. Moreover, Asia Pacific is anticipated to exhibit the fastest growth over the estimated period from 2020 to 2027. The rapidly developing countries including India and China are accelerating the regional market value. The increasing disposable income and rising investment by the government and industry players for the development of healthcare facilities in the region are additionally bolstering the regional market value.
The players profiled in the report include Arthrex, Inc. (Arthrex), Exactec Inc., Globus Medical, Inc., Integra LifeSciences Holdings Corporation, Johnson and Johnson (J&J), Medline Industries, Inc., NuVasive Inc., Stryker Corporation, Wright Medical Group, Inc., and Zimmer Biomet Holdings, Inc. The major orthobiologics players were involved in strategic developments for escalating the profit share in regional as well as global market. The major investments were announced for the technological advancements associated with the changing consumer demand for orthobiologics
Market Segmentation
Market By Product
Demineralized Bone Matrix (DBM)
Allograft
Bone Morphogenetic Protein (BMP)
Viscosupplementation Products
Synthetic Bone Substitutes
Others
Market By Application
Osteoarthritis and Degenerative Arthritis
Spinal Fusion
Fracture Recovery
Soft Tissue Injuries
Maxillofacial and Dental Applications
Market By End User
Hospitals, Orthopedic Clinics, and Ambulatory Care Centers
Research and Academic Institutes
Dental Clinics and Facilities
Market By Geography
North America
Europe
- U.K.
- Germany
- France
- Spain
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
Middle East & Africa
- GCC
- South Africa
- Rest of Middle East & Africa
CHAPTER 1. Industry Overview of Orthobiologics
1.1. Definition and Scope
1.1.1. Definition of Orthobiologics
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Orthobiologics Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Orthobiologics Market By Product
1.2.3. Orthobiologics Market By Application
1.2.4. Orthobiologics Market By End User
1.2.5. Orthobiologics Market by Regions
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restrain 1
3.2.2. Restrain 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Orthobiologics Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Orthobiologics Market
3.7. Value Chain Analysis
3.8. Regulatory Compliance
3.9. Competitive Landscape, 2019
3.9.1. Player Positioning Analysis
3.9.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Orthobiologics Market By Product
4.1. Introduction
4.2. Orthobiologics Revenue By Product
4.2.1. Orthobiologics Revenue (US$ Mn) and Forecast, By Product, 2016-2027
4.2.2. Demineralized Bone Matrix (DBM)
4.2.2.1. Demineralized Bone Matrix (DBM) Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.3. Allograft
4.2.3.1. Allograft Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.4. Bone Morphogenetic Protein (BMP)
4.2.4.1. Bone Morphogenetic Protein (BMP) Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.5. Viscosupplementation Products
4.2.5.1. Viscosupplementation Products Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.6. Synthetic Bone Substitutes
4.2.6.1. Synthetic Bone Substitutes Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.7. Others
4.2.7.1. Others Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 5. Orthobiologics Market Revenue By Application
5.1. Introduction
5.2. Orthobiologics Revenue (US$ Mn) By Application
5.2.1. Orthobiologics Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
5.2.2. Osteoarthritis and Degenerative Arthritis
5.2.2.1. Osteoarthritis and Degenerative Arthritis Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.3. Spinal Fusion
5.2.3.1. Spinal Fusion Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.4. Fracture Recovery
5.2.4.1. Fracture Recovery Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.5. Soft Tissue Injuries
5.2.5.1. Soft Tissue Injuries Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.6. Maxillofacial and Dental Applications
5.2.6.1. Maxillofacial and Dental Applications Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 6. Orthobiologics Market By End User
6.1. Introduction
6.2. Orthobiologics Revenue (US$ Mn) By End User
6.2.1. Orthobiologics Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
6.2.2. Hospitals, Orthopedic Clinics, and Ambulatory Care Centers
6.2.2.1. Hospitals, Orthopedic Clinics, and Ambulatory Care Centers Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.3. Research and Academic Institutes
6.2.3.1. Research and Academic Institutes Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.4. Dental Clinics and Facilities
6.2.4.1. Dental Clinics and Facilities Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 7. North America Orthobiologics Market By Country
7.1. North America Orthobiologics Overview
7.2. U.S.
7.2.1. U.S. Orthobiologics Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
7.2.2. U.S. Orthobiologics Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
7.2.3. U.S. Orthobiologics Market Revenue (US$ Mn) and Forecast By End User, 2016-2027
7.3. Canada
7.3.1. Canada Orthobiologics Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
7.3.2. Canada Orthobiologics Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
7.3.3. Canada Orthobiologics Market Revenue (US$ Mn) and Forecast By End User, 2016-2027
7.4. North America PEST Analysis
CHAPTER 8. Europe Orthobiologics Market By Country
8.1. Europe Orthobiologics Market Overview
8.2. U.K.
8.2.1. U.K. Orthobiologics Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
8.2.2. U.K. Orthobiologics Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
8.2.3. U.K. Orthobiologics Market Revenue (US$ Mn) and Forecast By End User, 2016-2027
8.3. Germany
8.3.1. Germany Orthobiologics Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
8.3.2. Germany Orthobiologics Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
8.3.3. Germany Orthobiologics Market Revenue (US$ Mn) and Forecast By End User, 2016-2027
8.4. France
8.4.1. France Orthobiologics Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
8.4.2. France Orthobiologics Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
8.4.3. France Orthobiologics Market Revenue (US$ Mn) and Forecast By End User, 2016-2027
8.5. Spain
8.5.1. Spain Orthobiologics Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
8.5.2. Spain Orthobiologics Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
8.5.3. Spain Orthobiologics Market Revenue (US$ Mn) and Forecast By End User, 2016-2027
8.6. Rest of Europe
8.6.1. Rest of Europe Orthobiologics Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
8.6.2. Rest of Europe Orthobiologics Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
8.6.3. Rest of Europe Orthobiologics Market Revenue (US$ Mn) and Forecast By End User, 2016-2027
8.7. Europe PEST Analysis
CHAPTER 9. Asia Pacific Orthobiologics Market By Country
9.1. Asia Pacific Orthobiologics Market Overview
9.2. China
9.2.1. China Orthobiologics Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
9.2.2. China Orthobiologics Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
9.2.3. China Orthobiologics Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
9.3. Japan
9.3.1. Japan Orthobiologics Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
9.3.2. Japan Orthobiologics Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
9.3.3. Japan Orthobiologics Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
9.4. India
9.4.1. India Orthobiologics Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
9.4.2. India Orthobiologics Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
9.4.3. India Orthobiologics Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
9.5. Australia
9.5.1. Australia Orthobiologics Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
9.5.2. Australia Orthobiologics Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
9.5.3. Australia Orthobiologics Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
9.6. South Korea
9.6.1. South Korea Orthobiologics Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
9.6.2. South Korea Orthobiologics Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
9.6.3. South Korea Orthobiologics Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
9.7. Rest of Asia-Pacific
9.7.1. Rest of Asia-Pacific Orthobiologics Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
9.7.2. Rest of Asia-Pacific Orthobiologics Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
9.7.3. Rest of Asia-Pacific Orthobiologics Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
9.8. Asia Pacific PEST Analysis
CHAPTER 10. Latin America Orthobiologics Market By Country
10.1. Latin America Orthobiologics Market Overview
10.2. Brazil
10.2.1. Brazil Orthobiologics Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
10.2.2. Brazil Orthobiologics Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
10.2.3. Brazil Orthobiologics Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
10.3. Mexico
10.3.1. Mexico Orthobiologics Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
10.3.2. Mexico Orthobiologics Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
10.3.3. Mexico Orthobiologics Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
10.4. Rest of Latin America
10.4.1. Rest of Latin America Orthobiologics Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
10.4.2. Rest of Latin America Orthobiologics Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
CHAPTER 11. Middle East & Africa Orthobiologics Market By Country
11.1. Middle East & Africa Orthobiologics Market Overview
11.2. Saudi Arabia
11.2.1. Saudi Arabia Orthobiologics Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
11.2.2. Saudi Arabia Orthobiologics Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
11.2.3. Saudi Arabia Orthobiologics Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
11.3. UAE
11.3.1. UAE Orthobiologics Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
11.3.2. UAE Orthobiologics Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
11.3.3. UAE Orthobiologics Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
11.4. Rest of Middle East & Africa
11.4.1. Rest of Middle East & Africa Orthobiologics Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
11.4.2. Rest of Middle East & Africa Orthobiologics Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
11.4.3. Rest of Middle East & Africa Orthobiologics Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
CHAPTER 12. Player Analysis Of Orthobiologics
12.1. Orthobiologics Market Company Share Analysis
12.2. Mergers And Acquisition In Global Orthobiologics Market
CHAPTER 13. Company Profile
13.1. Arthrex, Inc.
13.1.1. Company Snapshot
13.1.2. Business Overview
13.1.3. Financial Overview
13.1.3.1. Revenue (US$ Mn), 2019
13.1.3.2. Arthrex, Inc. 2019 Orthobiologics Business Regional Distribution
13.1.4. Product/ Service and Specification
13.1.5. Manufacturing Plant Footprint Analysis
13.2. Exactec Inc.
13.3. Globus Medical, Inc.
13.4. Integra LifeSciences Holdings Corporation
13.5. Johnson and Johnson
13.6. Medline Industries, Inc.
13.7. NuVasive Inc.
13.8. Stryker Corporation
13.9. Wright Medical Group, Inc.
13.10. Zimmer Biomet Holdings, Inc.
13.11. Others
